Single session of pattern scanning laser versus multiple sessions of conventional laser for panretinal photocoagulation in diabetic retinopathy: Efficacy, safety and painfulness

por Nemcansky, Jan, Stepanov, Alexandr, Nemcanska, Sabina, Masek, Petr, Langrova, Hana, Studnicka, Jan
Publicado 2019

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic

por Nemcansky, Jan, Stepanov, Alexandr, Koubek, Michal, Veith, Miroslav, Klimesova, Yun Min, Studnicka, Jan
Publicado 2019

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

por Stepanov, Alexandr, Pencak, Martin, Nemcansky, Jan, Matuskova, Veronika, Stredova, Marketa, Beran, David, Studnicka, Jan
Publicado 2020

Long-Term Outcomes of Rheohaemapheresis in the Treatment of Dry Form of Age-Related Macular Degeneration

por Studnička, Jan, Rencová, Eva, Bláha, Milan, Rozsíval, Pavel, Lánská, Miriam, Bláha, Vladimír, Němčanský, Jan, Langrová, Hana
Publicado 2013

Prognostic Factors of Early Morphological Response to Treatment with Ranibizumab in Patients with Wet Age-Related Macular Degeneration

por Chrapek, Oldřich, Jarkovský, Jiří, Šín, Martin, Studnička, Jan, Kolář, Petr, Jirková, Barbora, Dušek, Ladislav, Pitrová, Šárka, Řehák, Jiří
Publicado 2015

Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis

por Rencová, Eva, Bláha, Milan, Studnička, Jan, Bláha, Vladimír, Lánská, Miriam, Renc, Ondřej, Stepanov, Alexander, Kratochvílová, Věra, Langrová, Hana
Publicado 2015

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

por Prünte, Christian, Fajnkuchen, Franck, Mahmood, Sajjad, Ricci, Federico, Hatz, Katja, Studnička, Jan, Bezlyak, Vladimir, Parikh, Soumil, Stubbings, William John, Wenzel, Andreas, Figueira, João
Publicado 2016

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Cli...

por Woo, Se Joon, Veith, Miroslav, Hamouz, Jan, Ernest, Jan, Zalewski, Dominik, Studnička, Jan, Vajas, Attila, Papp, Andras, Gabor, Vogt, Luu, James, Matuskova, Veronika, Yoon, Young Hee, Pregun, Tamás, Kim, Taehyung, Shin, Donghoon, Bressler, Neil M.
Publicado 2020

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

por Woo, Se Joon, Bradvica, Mario, Vajas, Attila, Sagong, Min, Ernest, Jan, Studnicka, Jan, Veith, Miroslav, Wylegala, Edward, Patel, Sunil, Yun, Cheolmin, Orski, Michal, Astakhov, Sergei, Tóth-Molnár, Edit, Csutak, Adrienne, Enyedi, Lajos, Kim, Taehyung, Oh, Inkyung, Jang, Hyerin, Sadda, SriniVas R.
Publicado 2023

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

por Bressler, Neil M, Veith, Miroslav, Hamouz, Jan, Ernest, Jan, Zalewski, Dominik, Studnička, Jan, Vajas, Attila, Papp, András, Vogt, Gabor, Luu, James, Matuskova, Veronika, Yoon, Young Hee, Pregun, Tamás, Kim, Taehyung, Shin, Donghoon, Oh, Inkyung, Jeong, Hansol, Kim, Mercy Yeeun, Woo, Se Joon
Publicado 2023